| [1] |
Chen Y, Gao SG, Chen JM, et al. Serum CA242, CA199, CAl25, CEA, and TSGF aye biomaykers for the efficacy and prognosis of cryoa-blation in pancreatic cancer patients [J]. J Cell Biochem Biophys. 2015, 71(3): 1287-1291.
|
| [2] |
丁磊, 王海刚, 钱铮, 等. 3464例临床血清CA199异常增高分析 [J]. 中国伤残医学, 2015, 23(22): 192-194.
|
| [3] |
孟祥鹏, 王宝胜, 刘臻, 等. SDF-1与CA199在胰腺癌中的表达及临床意义 [J]. 现代肿瘤医学, 2014, 22(1): 131-133.
|
| [4] |
Aldakkak M, Christians KK, Krepline AN, et al. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer [J]. HPB (Oxford), 2015, 17(10): 942-952.
|
| [5] |
Kuisma M, Karppinen J, Niinimäki J, et al. Modic changes in endplates of lumbar vertebral bodies: prevalence and association with low back and sciatic pain among middle-aged male workers [J]. Spine(Phila Pa 1976). 2007, 32(10): 1116-1122.
|
| [6] |
颜海希, 郑静, 金霞霞, 等. 联合检测CA199、CA242、CEA对胰腺癌诊断价值的Meta分析 [J]. 肿瘤学杂志, 2013, 19(7): 532-538.
|
| [7] |
李文兵, 高波. 联合检测肿瘤标志物在消化系恶性肿瘤中的应用研究 [J]. 现代中西医结合杂志, 2014, 23(18): 1954-1956.
|
| [8] |
杨会生, 王韩, 汤宛莹, 等. 联合检测CA724、CA199、CEA对胃癌诊断价值的Meta分析 [J]. 肿瘤学杂志, 2015, 21(9): 714-720.
|
| [9] |
刘群, 张浩, 周亚军. CA199、CA125、CEA检测对不同分期胰腺癌、胃癌诊断价值比较 [J]. 医学信息, 2013(18): 600-600.
|
| [10] |
Liu X, Cai H, Wang Y. Prognostic significance of tumour markers in Chinese patients with gastric cancer [J]. Anz Journal of Surgery, 2014, 84(6): 448-453.
|
| [11] |
Ychou M, Duffour J, Kramar A, et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. [J]. Disease Markers, 2000, 16(3-4): 105-110.
|
| [12] |
He B, Zhang H Q, Xiong S P, et al. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma. [J]. Asian Pacific Journal of Cancer Prevention Apjcp, 2015, 16(8): 3111-3116.
|
| [13] |
Lindsey A, Freddie Bray, Rebecca L, et al. Global Cancer Statistics, 2012 [J]. CA CANCER J CLIN 2015; 00: 00-00.
|
| [14] |
李晓红, 杨丽, 李婉澜, 等. CA50及CA199在结肠癌患者中的临床应用价值 [J]. 检验医学与临床, 2015(21): 3248-3250.
|
| [15] |
陈蕾, 姜北海, 邸佳柏, 等. CA199在判断CEA正常的中晚期结直肠癌患者预后中的价值 [J]. 中国肿瘤临床, 2015, 42(15): 743-750.
|
| [16] |
Li A, Tan Z, Fu C, et al. Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years [J]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25; 20(1): 58-61.
|
| [17] |
沈世强. 胆囊癌早期诊断的实验研究现状及展望 [J]. 中华实验外科杂志, 2010, 27(7): 853-854.
|
| [18] |
张航宇, 窦科峰. 超声联合肿瘤标志物CA19-9及超敏C反应蛋白检测对胆囊癌早期诊断准确性的影响 [J]. 解放军医学杂志, 2014, 39(3): 222-225.
|
| [19] |
张永东. 血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究 [J]. 肝胆外科杂志, 2016, 24(2): 106-110.
|
| [20] |
Liu Y, Sun J, Zhang Q, et al. Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice [J]. Biomarkers in Medicine, 2017.
|
| [21] |
Jo J H, Chung M J, Park J Y, et al. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. [J]. Surgical Endoscopy, 2013, 27(11): 4210.
|
| [22] |
胡刚, 湛汇, 胡如进. 肝内胆管结石合并肝内胆管癌发病危险因素及预测指标分析 [J]. 胃肠病学和肝病学杂志, 2015, 24(6): 742-744.
|
| [23] |
支杰华, 高雪峰, 许松欣, 等. 小肠炎性纤维息肉导致CA199升高一例 [J]. 中华消化内镜杂志, 2016, 33(11): 806-807.
|
| [24] |
Zhou JP, Dong M, Zhang Y, et al. Giant mucinous biliary cystadenoma: a case report [J]. Hepatobiliary Pancreat Dis Int, 2007, 6(1): 101-103.
|
| [25] |
方恒忠, 陈炯, 赵金钱, 等. 血清学肿瘤标志物与胰腺癌诊断及分期的关系 [J]. 国际外科学杂志, 2016, 43(3): 171-173.
|
| [26] |
刘梦奇, 郭文治, 张水军. 癌抗原199在肝脏疾病中的基础研究进展 [J]. 中华实验外科杂志, 2016, 33(10): 2432-2434.
|
| [27] |
王淑君, 阮戈冲, 柏小寅, 等. 以急性胰腺炎为首发临床表现的胰腺癌1例 [J]. 胃肠病学和肝病学杂志, 2015, 24(10): 1281-1282.
|
| [28] |
Mujica VR, Barkin JS, Go VLW. Acute pancreatitis secondary to pancreatic carcinoma [J]. Pancreas 2000; 21: 329-32.
|
| [29] |
Chung SD, Chen KY, Xirasagar S, et al. More than 9-times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population [J]. Pancreas, 2012, 41(1): 142-146.
|
| [30] |
张玮玮. 血清CA199检测在梗阻性黄疸中的诊断价值 [J]. 山西医药杂志, 2014(16): 1975-1977.
|
| [31] |
Ramsey ML, Conwell D L, Hart PA. Complications of Chronic Pancreatitis [J]. Dig Dis Sci, 2017, 62(7): 1745-1750.
|
| [32] |
李明欣, 尚东, 徐贺, 等. 首发症状为急慢性胰腺炎的胰腺癌诊断与治疗 [J]. 中华消化外科杂志, 2014, 13(11): 859-863.
|
| [33] |
Mayerle J, Kalthoff H, Reszka R, et al. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis [J]. Gut, 2017, 67(1): 128-137.
|
| [34] |
Kaur S, Smith L M, Patel A, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study [J]. Am J Gastroenterol, 2017, 112(1): 172-183.
|
| [35] |
鲁琼, 贺铮雯, 张乐之, 等. 血清IgG4和CA199联合检测在自身免疫性胰腺炎和胰腺癌鉴别诊断中的意义 [J]. 检验医学, 2011, 26(11): 746-749.
|
| [36] |
Heerde M J V, Buijs J, Hansen B E, et al. Serum Level of Ca 19-9 Increases Ability of IgG4 Test to Distinguish Patients with Autoimmune Pancreatitis from Those with Pancreatic Carcinoma [J]. Dig Dis Sci, 2014, 59(6): 1322-1329.
|
| [37] |
董文志, 莫小华. 血清CA199在肝内外胆管结石表达的相关性研究[J/CD]. 世界最新医学信息文摘（电子版）, 2015, 26(11).
|
| [38] |
徐惠明, 周静. 血清CA199、胆系酶、胆红素在不同胆系良性疾病中的水平研究 [J]. 实用临床医药杂志, 2016, 20(11): 183-184.
|
| [39] |
熊会玲, 范彦, 胡美, 等. 血清CA199对良恶性胆道疾病的意义 [J]. 临床消化病杂志, 2013, 25(6): 327-329.
|
| [40] |
王丽. 肝硬化Child-Pugh评分与血清CA125、CA199水平的关系 [J]. 胃肠病学和肝病学杂志, 2015, 24(2): 210-212.
|
| [41] |
崔春吉. 血清CA199检测在肝硬化中的临床价值 [J]. 临床消化病杂志, 2016, 28(2): 79-80.
|
| [42] |
严宪才, 缪英年, 吴志光, 等. 肝硬化患者血清CA199水平升高的原因及临床意义 [J]. 广东医学, 2008, 29(12): 2071-2073.
|